LIGAND PHARMACEUTICALS INC's ticker is LGND and the CUSIP is 53220K504. A total of 325 filers reported holding LIGAND PHARMACEUTICALS INC in Q1 2018. The put-call ratio across all filers is 1.44 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2018 | $3,843,000 | +23.1% | 14,000 | -7.1% | 0.57% | +16.1% |
| Q2 2018 | $3,121,000 | -10.1% | 15,066 | -28.3% | 0.49% | -14.9% |
| Q1 2018 | $3,471,000 | +83.4% | 21,017 | -4.9% | 0.58% | +92.7% |
| Q3 2015 | $1,893,000 | -31.1% | 22,100 | -18.9% | 0.30% | -6.8% |
| Q2 2015 | $2,748,000 | -21.4% | 27,236 | -40.0% | 0.32% | -20.3% |
| Q1 2015 | $3,498,000 | +225.4% | 45,367 | +162.8% | 0.40% | +98.0% |
| Q2 2014 | $1,075,000 | -37.7% | 17,264 | -32.7% | 0.20% | -34.4% |
| Q1 2014 | $1,725,000 | +11.7% | 25,654 | -12.6% | 0.31% | +12.7% |
| Q4 2013 | $1,544,000 | +21.4% | 29,362 | -0.1% | 0.28% | +8.7% |
| Q3 2013 | $1,272,000 | -57.1% | 29,397 | -62.9% | 0.25% | -60.6% |
| Q2 2013 | $2,967,000 | – | 79,291 | – | 0.64% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Knott David M Jr | 115,000 | $12,937,000 | 4.12% |
| Stonepine Capital Management, LLC | 73,700 | $8,291,000 | 3.44% |
| VILLERE ST DENIS J & CO LLC | 510,843 | $57,464,000 | 3.41% |
| Chicago Capital, LLC | 491,717 | $55,313,000 | 2.38% |
| Orchard Capital Management, LLC | 73,596 | $8,279,000 | 2.35% |
| RICE HALL JAMES & ASSOCIATES, LLC | 344,969 | $38,806,000 | 1.55% |
| Smith, Graham & Co., Investment Advisors, LP | 86,834 | $9,768,000 | 1.02% |
| WOODSTOCK CORP | 64,050 | $7,205,000 | 0.84% |
| INVESTMENT MANAGEMENT OF VIRGINIA LLC | 37,246 | $4,190,000 | 0.74% |
| Stephens Investment Management Group LLC | 417,670 | $46,984,000 | 0.69% |